Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients.
Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients.
复制标题
卡那奴单抗治疗冷热蛋白相关周期性综合征的长期安全性和有效性：来自日本患者的开放标签 III 期关键研究的结果。
作者：
Yokota S;Imagawa T;Nishikomori R;Takada H;Abrams K;Lheritier K;Heike T;Hara T.
